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Abstract Episomal vectors, described for e⁄cient and regu-
lated expression of heterologous proteins in mammalian cells,
have the advantage that they persist in multiple copies in the cell
without integrating into the chromosome. To e⁄ciently express
heterologous proteins we used such a vector based on elements
of the Epstein^Barr virus (EBV), namely the sequences coding
for Epstein^Barr nuclear antigen 1 and the viral origin of rep-
lication. Because constitutive expression is often deleterious to
the cell, we combined the interferon-inducible Mx promoter with
this EBV-derived vector. This resulted in an e⁄cient and strictly
regulated expression of the reporter gene chloramphenicol ace-
tyltransferase (CAT) and of the neurotransmitter receptor h5-
HT1B, reaching levels of 16 ng CAT/mg cytoplasmic protein and
1300 fmol receptor/mg membrane protein, respectively. For both
proteins, the expression levels were in£uenced by the orientation
of the expression cassette. The higher expression in the favored
orientation did not result from a higher copy number of these
episomes. Northern analysis revealed a transcriptional read-
through from the thymidine kinase promoter on the episomal
vector, which interfered with the transcription of the heterolo-
gous gene in the less favored orientation.
1 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Heterologous expression of recombinant proteins has found
widespread use for the overproduction of therapeutically im-
portant proteins. A whole plethora of expression systems in
various cell types has been developed. Mammalian cell sys-
tems are of particular interest, since they provide more au-
thentic posttranslational modi¢cations of the recombinant
protein compared to prokaryotes and lower eukaryotes. E⁄-
cient vector systems for heterologous gene expression in mam-
malian cells are episomal vectors, e.g. vectors based on
sequences of Epstein^Barr virus (EBV) [1]. EBV is a gamma-
herpesvirus with a double-stranded DNA of 172 kb that is
episomally maintained in several cell lines. The latent origin
of replication of EBV (oriP) and Epstein^Barr nuclear antigen
1 (EBNA1) are the only viral elements necessary and su⁄cient
for stable episomal maintenance of the viral DNA in the host
cell ; consequently, these basic elements are included in the
proposed mammalian expression vector. OriP comprises two
non-contiguous regions, viz. the family of repeats (FR) and
the dyad symmetry (DS) containing 20 tandem imperfect cop-
ies and four related copies, respectively, of a 30-bp repeat
sequence. These 30 bp represent consensus sequences for
EBNA1 binding [2^5]. EBNA1, the only virally encoded pro-
tein required for episomal maintenance, has no enzymatic
functions correlated with replication such as an ATPase or
helicase function. Therefore replication is performed by the
host cell replication apparatus, which occurs in synchrony
with the host chromosomes, i.e. once per cell cycle [6^9]. Rep-
lication is mainly unidirectional ; it starts near the DS and is
initially bidirectional but stops near the FR, which contains a
replication fork barrier [10^12]. Upon cell division, the oriP-
containing plasmids are bound, via EBNA1, to metaphase
chromosomes, which interaction secures an equal distribution
to the daughter cells [13,14]. Another role for oriP in the
presence of EBNA1 is a transactivation function which de-
pends on the cell line used and on the promoter driving the
gene of interest, independently of its orientation [15]. How
EBNA1 mediates this transactivation function can only be
hypothesized; HIV Tat-associated 32-kDa protein, which
strongly interacts with EBNA1, was recorded to be implicated
in transactivation and might contribute to EBNA1-mediated
transactivation [16]. The use of this episomal vector for het-
erologous gene expression has some important and unique
characteristics compared to more conventional DNA-integrat-
ing vectors. First, high-level expression of the gene of interest
can be obtained, because the EBV vector can reach copy
numbers of more than 100/cell. Second, transfection e⁄ciency
in vitro is usually high, because no integration into the host
genome is required. With respect to gene therapy, EBV se-
quences are often combined with retroviral, adenoviral or
herpesviral sequences to further increase the gene delivery
e⁄ciency in vivo [17^19]. Finally, neither the gene of interest
nor the host cell DNA will su¡er from events peculiar to
chromosome integration, such as silencing and gene disrup-
tion e¡ects.
Another feature we focused on is the usage of inducible
expression systems. Constitutive expression of proteins is
often deleterious to the host cell and frequently results in
cell death or loss of highly expressing clones. Therefore, we
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integrated a type-I interferon (IFN)-inducible Mx promoter
[20] in the EBV-derived expression vector. Although this
IFN-inducible Mx system is an endogenous system and thus
probably su¡ers from pleiotropic e¡ects caused by the induc-
ing agent, it certainly has proven its utility for regulated ex-
pression of a variety of recombinant proteins [21^26]. This
combination resulted in a tightly controlled expression of
the reporter protein chloramphenicol acetyltransferase (CAT)
and of the neurotransmitter receptor h5-HT1B. In both cases,
the expression levels depended on the orientation of the ex-
pression cassette relative to other sequences of the EBV-de-
rived vector. A higher expression level was obtained when the
expression cassette had the same orientation as the EBV se-
quences and was opposite to the eukaryotic selection cassette.
Although it is well documented that the expression levels ob-
tained with episomal vectors are correlated with vector copy
number [27,28], Southern blot analysis revealed that this was
not the case. In contrast, we provide evidence that interfering
transcripts from the neighboring resistance gene co-determines
the expression level of the heterologous gene. As EBV-derived
expression vectors become more widely used, this aspect
should be taken into account for further research or applica-
tion purposes.
2. Materials and methods
2.1. Recombinant DNA constructions
The basal EBV-derived vector p220.2 [3] contains the viral sequen-
ces oriP and EBNA1, as well as the hygromycin B (hyg) selectable
marker gene driven by a thymidine kinase (TK) promoter for selection
in eukaryotes. The expression cassettes Mx/CAT/poly(A) or Mx/h5-
HT1B/poly(A), isolated by double restriction digestion from pMxCAT
and pMxh5-HT1B, respectively [26], were inserted in both orientations
at the SalI^XbaI site of p220.2 to obtain p220.2MxCAT orientation 1
(Or1) or p220.2Mx5-HT1B Or1 and at the XbaI-BamHI site to obtain
p220.2MxCAT Or2 or p220.2Mx5-HT1B Or2 (Fig. 1).
2.2. Cell culture and transfection
Vero (monkey) as well as MG63, HEK293 and HEK293EBNA1
(man) cells (Invitrogen, San Diego, CA, USA) were grown in Dulbec-
co’s modi¢ed Eagle’s medium (DMEM) supplemented with 10% new-
born calf serum, L-glutamine (2 mM), penicillin (100 U/ml) and strep-
tomycin (0.1 mg/ml). Transfections were carried out with standard
calcium phosphate DNA coprecipitation procedures, using 30 Wg
DNA.
As the use of EBV vectors usually results in higher transfection
e⁄ciency, the transfected cells were seeded at lower density before
selection with hyg (Vero, 300 U/ml; HEK293, 150 U/ml; MG63, 50
U/ml). After a selection period of 3 weeks, only single cell clones were
isolated for further study. Stable clones, containing EBV-derived vec-
tors, were kept under continuous selection [3].
2.3. Induction
Cell cultures were grown to subcon£uency. For induction of the Mx
promoter, the medium was replaced by DMEM with 10% serum
containing 1000 U/ml human IFN-K (PeproTech, Hill, NJ, USA).
After 24 h induction, cells were washed and lysates were prepared.
2.4. Reporter protein quanti¢cation
CAT expression was assayed with a quantitative home-developed
CAT-ELISA [24] and the results were statistically analyzed using the
Student’s t-test.
2.5. Radioligand binding
Cell cultures were transferred to Petri dishes and grown to subcon-
£uency. After 24 h induction, cells were washed with phosphate-bu¡-
ered saline (PBS) and stored at 370‡C for membrane preparation. h5-
HT1B receptor expression levels were determined by radioligand bind-
ing with [3H]alniditan as described previously [29]. Brie£y, h5-HT1B
receptor cell membrane preparations were incubated with 5 nM
[3H]alniditan for 30 min at 37‡C. Non-speci¢c binding of the radio-
ligand was estimated in the presence of 10 WM sumatriptan.
2.6. Southern blot analysis
Low-molecular-weight DNA was prepared as described [30]. In
order to minimize experimental inaccuracies, we accurately deter-
mined the cell number (in triplicate on two di¡erent dilutions) before
lysing the di¡erent samples. Furthermore, at the start of the DNA
extraction procedure, pMa58 plasmid DNA [31] was added to the cell
lysis bu¡er at a ¢nal concentration of 500 ng/ml and used as an
internal control for experimental reproducibility and DNA recovery.
Brie£y, 300 000 cells were spun down, washed twice with HBS and
subsequently lysed in 600 Wl Hirt extraction bu¡er (10 mM EDTA,
0,6% SDS; pH 7.6) for 20 min at 37‡C. The cell lysate was scraped o¡
the plates and transferred to an Eppendorf tube. 150 Wl of 5 M NaCl
was added and the tubes were gently inverted 10 times not to brake
the chromosomal DNA. After an overnight incubation at 4‡C, the
solution was centrifuged for 30 min at 12 000Ug at 4‡C. The super-
natant was transferred to a new Eppendorf tube and puri¢ed by
phenolization (3U) and ether extraction (2U). Finally, the DNA
was precipitated, washed with 70% ethanol and dissolved in 50 Wl
of 0,1UTE. After digestion, the DNA was separated on a 1.2% aga-
rose gel and subsequently transferred to a GenescreenPlus membrane
(Du Pont, Wilmington, DE, USA). The membrane was hybridized
with a 32P-labeled random-primed probe and washed as prescribed
by the manufacturer. Results were visualized with a PhosphorImager
(Bio-Rad, Richmond, CA, USA) and data were analyzed using Quan-
tity One software (Bio-Rad).
2.7. Northern blot analysis
Cells were grown to subcon£uency and treated with 1000 U/ml
IFN-K. After 6 h incubation, total RNA was isolated with an RNeasy
kit (Qiagen, Chatsworth, CA, USA). Isolated RNA was separated on
a 1% agarose gel in 20 mM phosphate bu¡er (pH 7.0) and transferred
to a Nylon66 membrane (Amersham Pharmacia Biotech, Rainham,
UK). Subsequent hybridization and revelations were performed as
described above.
2.8. Western blot analysis
To detect EBNA1, nuclear lysates were prepared. After washing
with ice-cold PBS, cells were lysed with bu¡er B1 (10 mM HEPES
pH 7.5, 10 mM KCl, 1 mM MgCl2, 5% glycerol, 0.5 mM EDTA pH
7.5, 0.1 mM EGTA pH 7.5, 2 mM Pefablock, 5% mercaptoethanol,
1 mM aprotinin and 1 Wg leupeptin) for 10 min on ice. After centrifu-
gation for 10 min at maximum speed, the pellet was lysed in bu¡er B2
(20 mM HEPES pH 7.5, 10 mM KCl, 1 mM MgCl2, 400 mM NaCl,
1% NP40, 20% glycerol, 0.5 mM EDTA pH 7.5, 0.1 mM EGTA pH
7.5, 2 mM Pefablock, 5% mercaptoethanol, 1 mM aprotinin and 1 Wg
leupeptin) for 10 min on ice. After centrifugation, the proteins in the
supernatant were separated on a sodium dodecyl sulfate^10% polyac-
rylamide gel under denaturing conditions and transferred to nitrocel-
lulose membranes (Schleicher and Schuell, Dassel, Germany). EBNA1
was detected using a 1:8000 dilution of a polyclonal rabbit anti-
EBNA1 antibody, followed by incubation with biotinylated anti-rab-
bit antibody (1:1000; Amersham Pharmacia Biotech) and ¢nally with
horseradish peroxidase-linked streptavidin (1:1000; Amersham Phar-
macia Biotech). Detection was performed by chemiluminescence ac-
cording to the manufacturer’s recommendations (Du Pont).
2.9. RT-PCR
RNA was isolated as described above. 2 Wl (5^10 Wg) RNA was
used for an RT-PCR reaction (Access RT-PCR kit; Promega Biotech,
Madison, WI, USA) and subsequently screened with speci¢c primer
pairs. The primer sequences used were (1) GTC AAC AGC GTG
CCG CAA GA, (2) CCA GGA AGC TCC TCT GTG TC,
(3) CAG CCT GAC CTC CTC TCA GT and (4) AGA GTC AGC
AGT AGC CTC AT. Reverse transcription was performed at 48‡C
for 45 min. For ampli¢cation, 35 cycles were applied (30 s at 94‡C,
1 min at 60‡C and 2 min at 68‡C).
3. Results
3.1. Enhanced gene expression using episomal vectors
An expression cassette containing the CAT gene under con-
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trol of the Mx promoter was cloned into the vector p220.2
in both orientations (Fig. 1). The episomal plasmids
p220.2MxCAT Or1 and Or2 were then stably transfected
into the cell lines MG63, HEK293 and Vero. To compare
the di¡erence in expression between an episomal and a chro-
mosomally integrated expression cassette, the same cell lines
were also transfected with the vector pMxCAT [26]. After
isolation of stably transfected single cell clones, cells were
left untreated or were induced with 1000 U/ml IFN-K for
24 h. For all cell lines tested, the CAT expression levels ob-
tained with the episomal vectors are clearly higher as com-
pared to the levels from the chromosome-integrating vector
pMxCAT (Table 1). Non-induced levels, i.e. background ex-
pression, remained very low and were even not detectable in
the majority of the clones (6 0.1 ng CAT/mg protein).
3.2. Expression levels are in£uenced by the orientation of the
expression cassette
A marked, statistically signi¢cant di¡erence in expression
level was consistently observed between the EBV-derived ex-
pression vectors p220.2MxCAT Or1 and p220.2MxCAT Or2
(Table 1). In the favorable Or1, the expression cassette is in
the same orientation as the EBNA1 gene and oriP, and op-
posite to the orientation of the hyg expression cassette, where-
as the expression cassette in Or2 is in the same orientation as
the preceding hyg resistance gene (Fig. 1). Moreover, this
di¡erence in expression level is not cell line-dependent nor
gene-speci¢c, as it was observed in several cell lines and also
when Vero was transfected with p220.2Mxh5-HT1B Or1 and
Or2 (Fig. 1 and Table 1). As earlier studies demonstrated that
the expression level of a heterologous gene on an episomal
vector is directly proportional to the vector copy number
[27,28], we investigated whether the more abundant expression
in Or1 is due to a higher copy number of p220.2MxCAT Or1.
Therefore, we selected four moderate and two high expressing
Vero clones of both orientations for further analysis. We in-
cluded the high expressing clones to really study the correla-
tion between expression level and DNA copy number. Low-
molecular weight DNA was isolated and quanti¢ed by South-
ern blot analysis. After quanti¢cation, these results in general
did not show the presence of a higher copy number in Or1 as
compared to Or2 (Fig. 2). On the contrary, an analysis of
clones with a similar expression level of CAT protein (see
Table 2), e.g. cl 1, cl 3 and cl 7 of Or1 vs. cl 3 and cl 4 of
Or2, suggests that the respective copy numbers in Or2 are at
least twice as high as in Or1. A comparison of clones with a
similar copy number (e.g. cl 3 Or1 vs. cl 1 Or2, or cl 10 and cl
11 Or1 vs. cl 6 and cl 11 in Or2) shows a yield of CAT protein
for Or1 that is twice as high as for Or2. We conclude that a
higher protein expression in Or1 is obviously not related to a
higher copy number of the expression vector. In a next step,
total RNA of several clones of Or1 and Or2 was extracted
before and after treatment with 1000 U/ml IFN-K for 6 h and
used for Northern blot analysis, applying a CAT mRNA-spe-
ci¢c probe (Fig. 2). After normalization with a GAPDH sig-
nal, the CAT protein levels correlated well with the CAT
mRNA levels. A combination of both results and a calcula-
tion of the RNA/DNA ratio indicate that the latter value in
Or1 is twice as high as in Or2 (Table 2). This clearly demon-
strates that the higher expression in Or1 does not result from
a higher gene copy number, but derives from a transcriptional
advantage in Or1 or a disadvantage in Or2.
3.3. Transcriptional interference
Two adjacent vector sequences can be considered to a¡ect
the transcription of the recombinant genes, namely the hyg
expression cassette and the oriP sequence. To further inves-
tigate this phenomenon, a Northern blot analysis was per-
formed with total RNA of various clones of Or1 and Or2.
Fig. 1. The EBV-derived vector p220.2. White bars represent EBV
sequences and black bars sequences for eukaryotic selection. The ex-
pression cassettes are inserted in both orientations (Or1 and Or2).
Table 1
Overview of IFN-K-induced expression levels of the reporter gene CAT and the neurotransmitter receptor h5-HT1B in di¡erent cell types (aver-
age of n di¡erent clones). Comparison between chromosome-integrating and episomal vectors
Reporter protein expression (ng/mg cytoplasmic protein)
pMxCAT p220.2MxCAT Or1 p220.2MxCAT Or2
Vero 0 (n=12)a 4.7 (n=11) 2.2 (n=13)*
MG63 0 (n=9)a 4.0 (n=6) 1.8 (n=5)**
HEK293 0.7 (n=8) 2.3 (n=6) 1.8 (n=5)
HEK293EBNA1 0.2 (n=7) 2.1 (n=18) ND
Neurotransmitter receptor expression (fmol/mg membrane protein)
pMxh5-HT1B p220.2Mxh5-HT1B Or1 p220.2Mxh5-HT1B Or2
Vero ND 950 (n=9) 300 (n=5)*
ND: not determined.
*P6 0.01 (Or1-Or2).
***P6 0.001 (Or1-Or2).
aIntegration of pMxCAT DNA into the chromosome was con¢rmed by Southern blot analysis.
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Careful analysis of the hybridization pattern obtained with a
CAT mRNA-speci¢c probe revealed the presence of di¡erent
transcripts (Fig. 3A). For both orientations, a doublet was
found corresponding to mRNA species of approximately
1550 and 1150 nucleotides (nt), respectively. The shorter tran-
script results from the use of an alternative splice donor site,
present in the CAT sequences, with the splice acceptor site in
the SV40 intron [32]. Besides these two transcripts, a third
speci¢c, but faint band was detected in Or2 only, correspond-
ing to an mRNA of approximately 3200 nt. This mRNA
seems to be constitutively produced and therefore not depen-
dent on IFN-K-induced expression. We hypothesize that this
transcript is initiated at the TK promoter, driving the hyg
gene, and is terminated near the SV40 poly(A) sequences of
the CAT expression cassette as a result of ine⁄cient termina-
tion at the TK poly(A) sequences (Fig. 3C). To further test
this hypothesis, we searched for the presence of hyg mRNA
sequences that are not terminated at the TK poly(A) site.
Speci¢c primer sets were designed to identify incorrectly ter-
minated mRNA by RT-PCR. The primer pairs 1/2 and 1/3
clearly show that not all hyg-mRNA transcription is correctly
terminated at the TK poly(A) site and that considerable tran-
scription read-through occurs (Fig. 3B). Furthermore, the use
of primer pair 1/4 also gave rise to a faint band of approx-
imately 3200 nt, which demonstrates transcriptional read-
through as far as the 3P-untranslated region (UTR) of the
expression cassette Mx/CAT (Fig. 3C).
3.4. Transcriptional activation
OriP has been described to exert a transcriptional activity
upon binding of EBNA1 [15]. As our previous experiments
did not exclude this possibility, we investigated the in£uence
of EBNA1 on the activation of the Mx promoter. We used a
HEK293EBNA1 cell line, overexpressing EBNA1; the over-
expression was checked by Western analysis (data not shown).
HEK293 and HEK293EBNA1 cells were stably transfected
with the parental vector p220.2 or with the expression vector
pMxCAT and p220.2MxCAT Or1. Southern analysis of epi-
somal DNA showed that the overexpression of EBNA1 did
not result in a higher copy number of the EBV-derived vector
(Fig. 4). The fact that both cell lines showed a comparable
copy number allowed to investigate the in£uence of EBNA1
overexpression on the transactivation of the Mx promoter.
Stable cell clones were induced with IFN-K for 24 h or left
untreated, cell lysates were prepared and CAT expression was
quanti¢ed. CAT expression in non-induced HEK293 and
HEK293EBNA1 cell clones was undetectable (detection limit
6 0.1 ng CAT/mg protein). CAT-ELISA of cell lysates of
induced cells revealed that there was no signi¢cant di¡erence
between the expression levels in HEK293 and HEK293-
Fig. 2. Southern blot analysis, CAT^ELISA and Northern blot analysis of di¡erent clones of Vero p220.2MxCAT Or1 and Or2. Top: Episo-
mal DNA isolated from di¡erent stable transfectants was digested with HindIII and subsequently separated on gel. After blotting, the mem-
brane was hybridized with a labeled oriP fragment. Hybridization of the blot with a labeled pMa58 fragment allowed to correct for experimen-
tal inaccuracy. Bottom: After 6 h induction, total RNA was isolated and separated on gel. After blotting, the membrane was hybridized with a
CAT mRNA-speci¢c probe (Fig. 3B) and then with a GAPDH-speci¢c probe as an internal control (I, induced; NI, non-induced).
Table 2
RNA/DNA determination for various CAT-expressing clones
CAT expression (ng/mg cytoplasmic protein) RNAa DNAb RNA/DNA
Or1
cl 1 3.1 2.2 5.9 0.4
cl 3 3.4 2.6 8.7 0.3
cl 7 3.9 ND 5.6 ND
cl 9 4.2 2.4 5.2 0.5
cl 10 13.2 9.4 14.4 0.7
cl 11 16.2 6.6 17.1 0.4
Or2
cl 1 1.5 1.8 8.3 0.2
cl 3 3.3 2.3 10.9 0.2
cl 4 3.0 1.5 12.3 0.1
cl 5 2.4 1.7 12.5 0.1
cl 6 6.9 4.1 15.1 0.3
cl 11 6.7 3.3 16.1 0.2
ND: not determined.
aNormalized CAT/GAPDH Northern blot analysis data.
bNormalized CAT/pMa58 Southern blot analysis data.
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EBNA1 cell clones, viz. 2.3 (n=6) and 2.1 (n=18) ng CAT/
mg cytoplasmic protein, respectively (Table 1).
4. Discussion
We recently demonstrated that EBV-derived plasmids, in
contrast to other episomal expression vectors, are not prone
to DNA rearrangements [26]. Therefore the applicability of
this mammalian expression vector in combination with an
inducible promoter was further examined. A higher expression
of the reporter protein CAT and the neurotransmitter recep-
tor h5-HT1B was obtained with the EBV-derived vectors in
the di¡erent cell lines tested as compared to chromosomally
integrated versions of the expression cassette. This most likely
results from the fact that they persist in multiple copies in the
cell. Furthermore, they are also not susceptible to control
mechanisms, peculiar to integration of foreign DNA into
the host chromosome, such as silencing. Such mechanisms
are probably responsible for the lack of CAT expression in
several of the Vero and MG63 pMxCAT clones.
The expression cassette Mx/CAT/poly(A) was inserted in
the parental vector p220.2 in two orientations, resulting in a
markedly higher expression level with Or1 than with Or2. The
di¡erence in expression level is not cell line-dependent or
gene-speci¢c, as it is also observed when the Vero cell line
was transfected with p220.2Mxh5-HT1B Or1 and Or2. A sim-
ilar orientation-dependent expression has been reported pre-
viously with a human IFN-Q transcriptional cassette inserted
in both orientations in an EBV-derived vector [33]. The results
clearly show that the expression cassette itself is not respon-
sible for this orientation-dependent e¡ect. Although several
investigators reported that the expression level of a heterolo-
gous gene on an episomal vector is correlated with vector
copy number [27,28], Southern blot analysis did not show
that the higher protein concentration in Or1 was due to a
higher copy number of the episomal vector but could be cor-
related with higher mRNA levels. A comparative Northern
blot analysis of several stable clones of both orientations re-
vealed the presence of a constitutive band of approximately
3200 nt in Or2 only. As this band was not in£uenced by
treatment with IFN-K, we hypothesized that this mRNA
was properly initiated at the TK promoter but not correctly
terminated near the TK poly(A) sequence, which provides less
e⁄cient poly(A) signals. This was con¢rmed by RT-PCR us-
ing speci¢c primer pairs discriminating between the various
mRNA species. There is a close correlation between e⁄cient
termination of transcription and e⁄ciency of the poly(A) sig-
nal [34]. Most eukaryotic mRNAs are cleaved posttranscrip-
tionally at a speci¢c site in the UTR, approximately 10^30 nt
downstream of a consensus sequence, i.e. the highly conserved
AAUAAA poly(A) signal. This sequence restricts transcrip-
tional progression, resulting in cleavage of the mRNA near
Fig. 4. Southern blot analysis of p220.2. Episomal DNA was iso-
lated from stably transfected HEK293 and HEK293EBNA1 cell
clones. Isolated DNA was linearized with HindIII, separated on a
1.2% agarose gel and transferred to a nitrocellulose membrane. The
membrane was hybridized with a 32P-labeled oriP fragment; the
control consisted of p220.2 plasmid DNA digested with HindIII.
Fig. 3. A: Northern blot analysis of various stable Vero p220.2MxCAT Or1 and Or2 clones. Total RNA was isolated and separated on gel.
After blotting, the membrane was hybridized with a CAT mRNA-speci¢c probe (NI, non-induced; I, induced). B: Part of the expression vector
showing the insert in both orientations with respect to the £anking selection marker module as well as the potentially di¡erent CAT mRNA
products generated (t, part of the SV40 small-t antigen). C: RT-PCR analysis of stably transfected Vero p220.2MxCAT Or1 (lanes 1^4) and
Or2 (lanes 5^8 and 9^11) cell clones. RNA was isolated and used in an RT-PCR reaction using the indicated primer pairs. As a control for
DNA contamination, lanes 1, 5 and 9 contain RNA samples where RT was omitted from the RT-PCR reaction. Lane 12 contains Vero paren-
tal cells (negative control). V represents V DNA digested with PstI (DNA size marker).
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this poly(A) site [34,35]. Both SV40E (early) and SV40L (late)
as well as the TK poly(A) sequences contain this conserved
hexanucleotide sequence. However, it was also shown that this
AAUAAA sequence is insu⁄cient for mRNA polyadenyla-
tion. Sequences such as GU- or U-rich elements more down-
stream of this cleavage site are also determining the strength
of the polyadenylation signal and can actually regulate the
choice between alternative upstream cleavage sites [35^38].
Polymerase release occurs closer to the poly(A) signal when
the latter is stronger [34]. The SV40L poly(A) sequence, for
instance, is more e⁄ciently used than other polyadenylation
signals [39,40]. The observed read-through of the hyg mRNA
certainly proceeds into the Mx promoter for Or2 with a few
transcripts going as far as the UTR. These incorrectly termi-
nated mRNAs will interfere with transcription initiation at
this promoter sequence and may thus account for the lower
expression levels in Or2. Such interference e¡ect is well docu-
mented for duplicated gene constructions and can occur over
a distance of more than 1000 bases [41]. It has also been
shown that binding of transcription factors to such an oc-
cluded promoter is reduced [42].
Besides the in£uence of the hyg expression cassette on
neighboring transcription, an in£uence of oriP could not be
ruled out. It has been demonstrated that the FR of oriP, upon
binding of EBNA1, can act as a transcriptional enhancer.
Although the extent of enhancement varies with promoter
and cell type, it is exerted across 10 kb of viral DNA and is
orientation-independent [10,15,43,44]. Therefore it is less
likely that this contributes to the observed di¡erence in ex-
pression levels between Or1 and Or2. The observation that the
use of the MSV or CMV enhancer did not alleviate this ori-
entation e¡ect [33], further contradicts this assumption. More-
over, EBNA1 overexpression could not increase the transac-
tivation function of oriP, as we obtained comparable CAT
expression levels in HEK293 and HEK293EBNA1 cells. Our
results show that read-through transcription from the TK
promoter interferes with the e⁄ciency of initiation at the
Mx promoter in Or2, resulting in a decreased expression of
the heterologous protein of interest. The observation should
be taken into account when using this episomal vector system
for expression of heterologous gene products.
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